Advanced Malignant Tumors Lymphomas
1 clinical trials · Condition
◉ Watch Advanced Malignant Tumors Lymphomas
| Record | Firm | Date |
|---|---|---|
| A Phase 1a Study Evaluating the Safety, Tolerability, and Efficacy of IBI322 in Subjects With Advanced Cancers (NCT04338659) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-01-14 |
Track Advanced Malignant Tumors Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.